Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
670 Grams, Birmingham B9 : ‘A cascade of small, meaningful bowls that just ooze flavour’ – restaurant review | Grace Dent on restaurants
19/10/2025
I want to marry my girlfriend, but I’m worried it may upset my young son
19/10/2025
The return of ‘Tescopoly’ ? How Britain’s biggest retailer dominates everyday life
19/10/2025
Spare us from romcom Austen. Give me the dark side of 19th-century life any day | Rhiannon Lucy Cosslett
19/10/2025
Italian blasphemy and German ingenuity : how swear words differ around the world
19/10/2025
Should friendship really be a ‘one strike and you’re out’ deal ?
19/10/2025